Literature DB >> 22521971

Leishmanicidal activity in vitro of Musa paradisiaca L. and Spondias mombin L. fractions.

Marina Parissi Accioly1, Claudia Maria Leal Bevilaqua, Fernanda C M Rondon, Selene Maia de Morais, Lyeghyna K A Machado, Camila A Almeida, Heitor Franco de Andrade, Roselaine P A Cardoso.   

Abstract

Visceral leishmaniasis (VL) is a zoonotic disease characterized by infection of mononuclear phagocytes by Leishmania chagasi. The primary vector is Lutzomyia longipalpis and the dog is the main domestic reservoir. The control and current treatment of dogs using synthetic drugs have not shown effectiveness in reducing the incidence of disease in man. In attempt to find new compounds with leishmanicidal action, plant secondary metabolites have been studied in search of treatments of VL. This study aimed to evaluate the leishmanicidal activity of Musa paradisiaca (banana tree) and Spondias mombin (cajazeira) chemical constituents on promastigotes and amastigotes of L. chagasi. Phytochemical analysis by column chromatography was performed on ethanol extracts of two plants and fractions were isolated. Thin layer chromatography was used to compare the fractions and for isolation the substances to be used in vitro tests. The in vitro tests on promastigotes of L. chagasi used the MTT colorimetric method and the method of ELISA in situ was used against amastigotes besides the cytotoxicity in RAW 264.7 cells. Of the eight fractions tested, Sm1 and Sm2 from S. mombin had no action against promastigotes, but had good activity against amastigotes. The fractions Mp1 e Mp4 of M. paradisiaca were very cytotoxic to RAW 264.7 cells. The best result was obtained with the fraction Sm3 from S. mombin with IC(50) of 11.26 μg/ml against promastigotes and amastigotes of 0.27 μg/ml. The fraction Sm3 characterized as tannic acid showed the best results against both forms of Leishmania being a good candidate for evaluation in in vivo tests.
Copyright © 2012. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22521971     DOI: 10.1016/j.vetpar.2011.12.029

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  5 in total

1.  Genotoxicity and antigenotoxicity study of aqueous and hydro-methanol extracts of Spondias mombin L., Nymphaea lotus L. and Luffa cylindrical L. using animal bioassays.

Authors:  Ifeoluwa Temitayo Oyeyemi; Olaide Maruf Yekeen; Paul Olayinka Odusina; Taiwo Mary Ologun; Orezimena Michelle Ogbaide; Olayinka Israel Olaleye; Adekunle A Bakare
Journal:  Interdiscip Toxicol       Date:  2015-12

2.  Leishmanicidal and fungicidal activity of lipases obtained from endophytic fungi extracts.

Authors:  Daniela Ribeiro Alves; Selene Maia de Morais; Fernanda Tomiotto-Pellissier; Fábio Roger Vasconcelos; Francisco das Chagas Oliveira Freire; Isaac Neto Goes da Silva; Alan Henrique Depieri Cataneo; Milena Menegazzo Miranda-Sapla; Gustavo Adolfo Saavedra Pinto; Ivete Conchon-Costa; Arlindo de Alencar Araripe Noronha; Wander Rogério Pavanelli
Journal:  PLoS One       Date:  2018-06-18       Impact factor: 3.240

3.  Bactericidal Effect of the Leaf Extract from Musa spp. (AAB Group, Silk Subgroup), cv. "Manzano" Against Multidrug-Resistant Mycobacterium tuberculosis.

Authors:  Gloria María Molina-Salinas; Andrés Humberto Uc-Cachón; Luis Manuel Peña-Rodríguez; Angel de Jesús Dzul-Beh; Rosa María Escobedo Gracía-Medrano
Journal:  J Med Food       Date:  2019-07-10       Impact factor: 2.786

4.  Antimicrobial Activity against Oral Pathogens Confirms the Use of Musa paradisiaca Fruit Stalk in Ethnodentistry.

Authors:  Ernest Owusu-Boadi; Mainprice Akuoko Essuman; Gabriel Mensah; Emmanuel Ayamba Ayimbissa; Alex Boye
Journal:  Evid Based Complement Alternat Med       Date:  2021-09-04       Impact factor: 2.629

5.  Poly herbal formulation with anti-elastase and anti-oxidant properties for skin anti-aging.

Authors:  Induja Kalyana Sundaram; Deepika Deeptirekha Sarangi; Vignesh Sundararajan; Shinomol George; Sahabudeen Sheik Mohideen
Journal:  BMC Complement Altern Med       Date:  2018-01-29       Impact factor: 3.659

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.